TIN

Kidney

Report in 12Hrs

At Home

No Fasting Required

Details

Biopsy for Tubulointerstitial Nephritis.

₹1,406₹2,009

30% OFF

TIN (Tinea Infection Nucleic Acid) Test - Comprehensive Medical Information Guide

Why is it done?
- Detects and identifies dermatophyte fungi responsible for tinea infections (ringworm, athlete's foot, jock itch)
- Diagnoses fungal skin infections when clinical presentation is unclear or differential diagnosis is needed
- Identifies specific causative organisms (Trichophyton, Epidermophyton, Microsporum species) to guide appropriate treatment
- Performed when patients present with pruritic rashes, scaling, maceration, or discoloration on feet, groin, or skin folds
- Used to monitor treatment efficacy and determine cure in recurrent or resistant infections
- Epidemiologically useful for tracking fungal species prevalence in clinical and community settings
Normal Range
- Negative Result: No dermatophyte DNA detected; indicates absence of tinea infection or negative fungal colonization
- Positive Result: Dermatophyte DNA detected; identifies specific fungal species present (expressed as CT value or cycle threshold in qPCR assays; typically <35 indicates positive detection)
- Units of Measurement: Cycle Threshold (CT) values, DNA copy number, or qualitative positive/negative reporting depending on methodology
- Interpretation Context: Results must be correlated with clinical presentation; positive test with asymptomatic colonization may not require treatment, while positive result with clinical symptoms warrants antifungal therapy
Interpretation
- Negative Result (No Dermatophyte DNA Detected):
  - Rules out tinea infection; clinical symptoms likely due to other causes (contact dermatitis, bacterial infection, eczema, candidiasis)
  - May indicate successful antifungal treatment and cure of previous infection
  - Insufficient specimen or improper sampling may rarely result in false negatives
- Positive Result (Dermatophyte DNA Detected):
  - Confirms dermatophyte infection; identifies specific organism genus/species (e.g., Trichophyton rubrum, Trichophyton mentagrophytes, Epidermophyton floccosum)
  - Clinical correlation essential; organism identification guides optimal antifungal selection and duration of therapy
  - Higher CT values (closer to 35) may indicate lower fungal load or early stage infection
  - Lower CT values indicate higher fungal DNA concentration, suggesting active infection or heavy colonization
- Factors Affecting Test Results:
  - Proper specimen collection (adequate scale/debris from affected area is critical for sensitivity)
  - Recent topical antifungal application may reduce organism detection and yield false negatives
  - Specimen storage time and temperature conditions affect DNA preservation and result validity
  - Immunocompromised patients may show atypical presentations or higher fungal loads
  - Environmental contamination during collection or processing is rare but possible with adequate quality controls
- Clinical Significance:
  - Positive test result combined with clinical symptoms confirms tinea diagnosis and justifies antifungal therapy initiation
  - Species identification (dermatophyte taxonomy) helps predict treatment response and prognosis
  - Negative result in clinically suspicious cases may warrant repeat testing or alternative diagnostic modality (KOH mount, fungal culture)
  - Provides epidemiological data regarding prevalence of specific dermatophyte species in geographic regions and populations
Associated Organs
- Primary Organ Systems:
  - Integumentary system (skin): primary site of dermatophyte colonization and infection
  - Hair follicles and roots: involved in tinea capitis (ringworm of scalp)
  - Nails (keratin-containing structures): affected in onychomycosis (fungal nail infection)
- Common Infections Detected:
  - Tinea pedis (athlete's foot): most common dermatophyte infection affecting feet and toes
  - Tinea cruris (jock itch): infection of groin and inner thighs, more common in males
  - Tinea corporis (body ringworm): circular lesions on trunk and extremities
  - Tinea capitis (scalp ringworm): particularly common in children with patchy alopecia and scaling
  - Onychomycosis (nail fungus): affects toenails and fingernails with discoloration, thickening, and crumbling
- Associated Medical Conditions:
  - Diabetes mellitus: hyperglycemia creates favorable environment for dermatophyte proliferation
  - Immunosuppression (HIV/AIDS, chemotherapy, organ transplant): increased susceptibility and more severe infections
  - Atopic dermatitis and other chronic skin conditions: impaired skin barrier function increases fungal colonization
  - Peripheral vascular disease: impaired circulation reduces immune response to fungal infection
- Potential Complications:
  - Secondary bacterial infection: scratching and skin barrier breakdown allow bacterial superinfection
  - Cellulitis: severe inflammation and infection can progress to deeper soft tissue involvement
  - Chronic treatment-resistant infections: recurrent tinea with limited therapeutic response in immunocompromised individuals
  - Autosensitization reaction (id reaction): generalized dermatitis triggered by fungal antigens in severe infections
Follow-up Tests
- Recommended Confirmatory or Adjunctive Tests:
  - Fungal culture on Sabouraud dextrose agar or other selective media: confirms TIN results and allows susceptibility testing for antifungal agents
  - KOH (Potassium Hydroxide) mount microscopy: rapid, inexpensive screening for dermatophyte elements when nucleic acid testing inconclusive
  - Histopathological examination with PAS staining: confirms fungal elements in tissue samples when diagnosis uncertain
  - Wood's lamp examination: assists in differential diagnosis but not definitive for dermatophyte identification
- Tests for Monitoring Treatment Response:
  - Repeat TIN testing after 4-6 weeks of therapy: demonstrates clearance of dermatophyte DNA confirming treatment success
  - Repeat fungal culture: particularly important for onychomycosis where prolonged therapy (6-12 months) is required
  - Clinical assessment combined with follow-up testing: photographic documentation of lesion resolution supplements laboratory results
- Tests for Evaluating Complications or Severe Infection:
  - Bacterial culture: if secondary bacterial infection suspected in cases with increased purulence or systemic signs
  - Blood glucose testing: assess for diabetes mellitus as risk factor in patients with severe or recurrent tinea
  - HIV testing: appropriate when patient presents with extensive, treatment-resistant dermatophyte infection
  - Liver function tests: baseline assessment before initiating systemic antifungal therapy (especially griseofulvin or azole medications)
- Monitoring Frequency:
  - Tinea pedis and corporis: clinical assessment every 2-3 weeks during treatment; follow-up testing at 4-6 weeks post-therapy initiation
  - Tinea capitis: clinical evaluation every 1-2 weeks; fungal culture follow-up at 4 weeks to confirm microbial clearance in children
  - Onychomycosis: monthly assessments during long-term therapy; testing at 3, 6, and 12 months to monitor progressive nail growth and fungal clearance
  - Recurrent infections: testing at each recurrence to determine if relapse (same organism) or reinfection (different species)
Fasting Required?
- Fasting: NO fasting required
- Specimen Type: Skin scales, nail debris, or hair collected from affected areas; non-invasive, minimally uncomfortable collection
- Patient Preparation Instructions:
  - Do NOT wash or cleanse the affected area for at least 24 hours before specimen collection to preserve fungal material
  - Discontinue all topical antifungal medications for at least 2 weeks before testing to avoid false-negative results
  - Stop systemic antifungal therapy for minimum 2-4 weeks before testing if medically appropriate
  - Avoid excessive moisture or sweating on collection day; keep area as dry as possible until collection
  - No need to avoid eating, drinking, or medications not directly affecting the skin site being tested
- Specimen Collection Details:
  - Scrape affected skin margins and active borders with sterile spatula or scalpel; collect crumbly debris
  - For nail infections: trim affected nail debris and file the nail bed; collect material in sterile container
  - For hair loss (tinea capitis): pluck 10-15 affected hairs with follicles using sterile tweezers
  - Place specimens in sterile, clean container without fixative; refrigerate if storage >2 hours before analysis
  - Label specimen clearly with patient name, date/time of collection, specimen source, and any relevant clinical information
- Medications to Avoid Before Testing:
  - Topical antifungal creams/ointments (terbinafine, azoles, tolnaftate, etc.): discontinue 2 weeks before testing
  - Systemic antifungal medications (griseofulvin, azoles, terbinafine): discontinue 2-4 weeks prior
  - Topical corticosteroids: may suppress local immune response and reduce organism detection
  - Antibacterial soaps or lotions: avoid immediately before testing as they may affect specimen integrity
  - Non-affected areas may be treated with other medications; only antifungal therapies need cessation
- Other Special Considerations:
  - Comfort and ease: can be performed at any time without dietary restrictions or fasting
  - Minimal risk: non-invasive collection carries negligible risk of adverse effects
  - No contraindications: appropriate for all ages including children, pregnant women, and elderly patients
  - Timing: test preferably when lesion is not macerated or oozing; dry lesions yield better specimens

How our test process works!